NEW YORK (GenomeWeb News) – Metabolon today said that it has completed its acquisition of Lipomics Technologies for an undisclosed amount.

Lipomics' laboratory facilities will remain at the company's headquarters in Sacramento, Calif., while Metabolon will keep its headquarters and laboratories in Research Triangle Park, NC. Steven Watkins, the founder of Lipomics, is joining Metabolon as chief technology officer.

The combined company now has 140 employees and 450 clients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.